Englese Thomas 4
4 · AZIYO BIOLOGICS, INC. · Filed Mar 10, 2021
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2021-03-08+22,500→ 22,500 totalExercise: $14.53Exp: 2031-03-08→ CLASS A COMMON STOCK (22,500 underlying) - Award
RESTRICTED STOCK UNITS
2021-03-08+3,750→ 3,750 total→ CLASS A COMMON STOCK (3,750 underlying)
Footnotes (3)
- [F1]This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
- [F3]The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date.